International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries

International Journal of Cardiology

Volumn 175, Issue 2, 2014, Pages 240-247

  McNamara, R L ^a   Chung, S C ^b   Jernberg, T ^c   Holmes, D ^d   Roe, M ^d   Timmis, A ^e   James, S ^f   Deanfield, J ^b   Fonarow, G C ^g   Peterson, E D ^d   Jeppsson, A ^h   Hemingway, H ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e National Institute for Health Research Biomedical Research Unit Barts Health London ^*  (United Kingdom)

^f UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^g UCLA MEDICAL CENTER   (United States)

^h SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Clinical registries; International comparisons; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTICOAGULANT AGENT;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; RISK FACTOR; SMOKING; SWEDEN; UNITED KINGDOM; UNITED STATES; VERY ELDERLY; COMPARATIVE STUDY; DISEASE MANAGEMENT; GREAT BRITAIN; INTERNATIONAL COOPERATION; MIDDLE AGED; MYOCARDIAL INFARCTION; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DISEASE MANAGEMENT; FEMALE; GREAT BRITAIN; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; SWEDEN; UNITED STATES;

EID: 84904270417     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.04.270     Document Type: Article

References (33)

1. FRagmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study Lancet 354 1999 708 715
2. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos et al. N Engl J Med 25 2001 1879 1887
3. K.A.A. Fox, P.A. Poole-Wilson, and R.A. Henderson et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial Lancet 360 2002 743 751
4. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST- elevation myocardial infarction (updating the 2007 Guideline). Developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 57 2011 1920 1959
5. J.P. Bassand, C.W. Hamm, and D. Ardissino et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology Eur Heart J 28 2007 1598 1660
6. H.H. Gray, R.A. Henderson, M.A. de Belder, R. Underwood, A.J. Camm, and on behalf of the guideline development group Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance Heart 96 2010 1662 1668
7. Developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on performance measures J Am Coll Cardiol 52 2008 2046 2099
8. M.T. Roe, J.C. Messenger, and W.S. Weintraub et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention J Am Coll Cardiol 56 2010 254 263
9. R.H. Mehta, M.T. Roe, and A.Y. Chen et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes. Insights from the CRUSADE Initiative Arch Intern Med 166 2006 2027 2034
10. E.D. Peterson, B.R. Shah, and L. Parsons et al. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990-2006 Am Heart J 156 2008 1045 1055
11. A.J. Bagnall, S.G. Goodman, and K.A.A. Fox et al. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes Am J Cardiol 103 2009 1530 1536
12. K. Szummer, P. Lundman, and S.H. Jacobson et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register Int Med 268 2010 40 49
13. E.H. Bradley, J. Herrin, and J.A. Mattera et al. Hospital-level performance improvement: beta-blocker use after acute myocardial infarction Med Care 42 2004 591 599
14. U. Stenestrand, J. Lindback, and L. Wallentin Hospital traditions influence long-term survival in patients with acute myocardial infarction Am Heart J 149 2005 82 90
15. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, M. Klein, G.A. Lamas, M. Packer, J. Rouleau, J.L. Rouleau, J. Rutherford, J.H. Wertheimer, and C.M. Hawkins Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial. N Engl J Med 327 10 1992 669 677
16. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335(11):775-82.
17. S. Yusuf, M. Flather, and J. Pogue et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators Lancet 352 9127 1998 507 514
18. K.A.A. Fox, S.G. Goodman, and F.A. Anderson et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1414 1424
19. P.G. Steg, J. Lopez-Sendon, and E. Lopez de Sa et al. External validity of clinical trials in acute myocardial infarction Arch Intern Med 2007 68 73 [b]
20. E. Herrett, L. Smeeth, L. Walker, C. Weston, and on behalf of the MINAP Investigators The Myocardial Ischaemia National Audit Project (MINAP) Heart 96 16 2010 1264 1267
21. T. Jernberg, M.F. Attebring, and K. Hambraeus et al. The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) Heart 96 2010 1617 1621
22. E.D. Peterson, M.T. Roe, and J.S. Rumsfeld et al. A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction Circ Cardiovasc Qual Outcomes 2 2009 491 499
23. J.C. Messinger, K.K.L. Ho, and C.H. Young et al. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012 J Am Coll Cardiol 60 16 2012 1484 1488
24. R. Carlhed, M. Bojestig, A. Peterson, C. Aberg, H. Garmo, and B. Lindahl Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative Circ Cardiovasc Qual Outcomes 2 2009 458 464
25. S. Larsson, P. Lawyer, G. Garellick, B. Lindahl, and M. Lundström Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value Health Aff 31 2012 220 227
26. N.H.S. Improvement National roll-out of Primary PCI for patients with ST segment elevation myocardial infarction: an interim report 2010
27. J. Harnek, J. Nilsson, and O. Friberg et al. The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART) Scand Cardiovasc J 47 Suppl. 62 2013 June 1 10
28. O.H. Dabbou, F.A.A. Anderson, and J.M. Ggore et al. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes Heart 94 2008 159 165
29. A.T. Yan, P. Jong, and R. Yan et al. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome Am Heart J 148 2004 1020 1027
30. J.S. Alpert Are data from clinical trials of any value? Eur Heart J 21 2000 1399 1401
31. A.K. Gitt, H. Bueno, and N. Danchin et al. The role of cardiac registries in evidence-based medicine Eur Heart J 10 2010 1093 1097
32. R.L. McNamara Cardiovascular registry research comes of age Heart 96 12 2010 908 910
33. E. Herrett, A.D. Shah, and R. Boggon et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study Br Med J 346 2013 f2350